Clinical Trial to Explore the Efficacy and Safety of DA-4001 After Topical Application

• Status: Completed
• Trial end date: 2014-12-01
• Target enrollment: 0
• Participant gender: Male

Summary

This study is designed to explore the efficacy and safety of DA-4001 after topical application in male patients with androgenetic alopecia

Design : Randomized, double-blind, active-controlled study

Investigational Product : Finasteride, minoxidil

• Phase: Phase 1/Phase 2
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Dong-A ST Co., Ltd.
• Treatments: Minoxidil

Criteria

Inclusion Criteria:

• Basic and specific(BASP) classification : basic type is M2 or C2 and specific type is V1,V2 or F1,F2

Exclusion Criteria:

• Evidence of hair loss other than androgenetic alopecia

• Use of finasteride, dutasteride within previous 12 months

• Use of minoxidil within previous 6 months

• Use of androgenic or anti-androgenic agents within previous 6 months

• Use of steroid agents for local application to scalp or systemic application within previous 1 month

• History of hair transplantation, scalp reduction

• Coronary artery disease, arrhythmia, congestive heart failure, valvular haert disease, angina pectoris